InnoBio Fund Overview
- Fund Type
-
Venture
- Fund Status
-
Closed
- Fund Manager
- CDC Enterprises
- (You're viewing 1 of 2)
- Size
-
- Vintage
-
2010
- Dry Powder
-
InnoBio Fund General Information
Description
InnoBio Fund is a 2010 vintage venture capital fund CDC Enterprises and Bpifrance. The fund is located in Paris, France. The targets companies that provide innovative technology products and services in the healthcare market.
Contact Information
Fund Manager's Location
- 137, rue de l'Université
- 75007 Paris
- France
InnoBio Fund Investments (27)
InnoBio Fund has made a total of 27 investments. Its most recent deal was a with ENYO Pharma for . The deal was made on 03-Jan-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| ENYO Pharma | 03-Jan-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Alentis Therapeutics | 13-Apr-2023 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Tridek-One | 11-Jul-2022 | Drug Discovery | Generating Revenue | |||
| Atelier Poitevin D'etiquettes - APE | 27-Jul-2016 | Printing Services (B2B) | Profitable | |||
| GamaMabs Pharma | 15-Dec-2015 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Annapurna Therapeutics | 12-Feb-2015 | Drug Discovery | Generating Revenue | |||
| Sensorion | 20-Jan-2015 | Biotechnology | Startup | |||
| Alizé Pharma | 10-Sep-2014 | Pharmaceuticals | Generating Revenue | |||
| Open Wide | 26-Jun-2014 | Buyout/LBO | IT Consulting and Outsourcing | Profitable | ||
| Lysogene | 21-May-2014 | Early Stage VC (Series A) | Biotechnology | Startup |
InnoBio Fund Investment Strategy
Investments by Industry
Investments by Deal Type
InnoBio Fund Limited Partners (7)
GSK is one of InnoBio Fund’s 7 limited partners. Its latest Original was on 17-Nov-2009.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| GSK | Current | 17-Nov-2009 | Original | ||
| Ipsen (Pharmaceuticals) | Current | 17-Nov-2009 | Original | ||
| Lilly Ventures | Current | 17-Nov-2009 | Original | ||
| Novartis Venture Fund | Current | 17-Nov-2009 | Original | ||
| Pfizer Ventures | Direct Investment | Current | 17-Nov-2009 | Original |
InnoBio Fund Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
InnoBio Fund Benchmark (3)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| National Fund for Digital Society | |||||
| Accel London III | |||||
| Energy Ventures IV | 31-Dec-2024 |
InnoBio Fund FAQs
-
What is InnoBio Fund?
InnoBio Fund is a 2010 vintage venture capital fund CDC Enterprises and Bpifrance.
-
Who manages InnoBio Fund?
InnoBio Fund is managed by CDC Enterprises and Bpifrance.
-
Where is InnoBio Fund domiciled?
InnoBio Fund is domiciled in France.
-
What is InnoBio Fund's size?
InnoBio Fund has a size of .
-
What type of fund is InnoBio Fund?
The fund type of InnoBio Fund is Venture.
-
What is the status of InnoBio Fund?
InnoBio Fund is closed.
-
What has InnoBio Fund invested in?
InnoBio Fund has made numerous investments in companies like ENYO Pharma, Alentis Therapeutics, and Tridek-One within the Drug Discovery industry.
-
What has InnoBio Fund invested in recently?
InnoBio Fund's latest investment was on 03-Jan-2024 in ENYO Pharma, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
